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ABSTRACT
Cells dying by the process of apoptosis, also termed programmed 
cell death, undergo a number of morphological changes. Apoptosis 
selectively determines cells to die by the activation of a cascade 
of biochemical pathways and certain death genes. Key features of 
this process are a dramatic reduction in cell volume and blebbing 
of the cell membrane, the degradation of the DNA into 200 bp 
fragments and the condensation of the chromatin at the nuclear 
membrane. Finally, small vesicles (apoptotic bodies) are formed 
containing organelles, DNA-fragments and cytoplasm. The apoptotic 
bodies are then recognized and removed by macrophages and other 
phagocytic cells.
The whole process is energy-dependent and requires the expression 
of proteins. It is assumed that these proteins participate in the 
regulation of apoptosis by functioning either as signal transducer 
or phagocyte recruitment signals. These functions would pre­
dominantly place them into the cell membrane or its vicinity. The 
APO-1 and TNF receptors are already known for their involvement 
in regulating apoptosis but are also present in non-apoptotic cells.
This study aims to investigate the novel expression of proteins at 
the surface of cells during apoptosis. HeLa, MCF-7, and HL60 cells 
were induced to undergo apoptosis by the addition of 5mM 6-DMAP, 
15 nM okadaic acid, and 2 j iM colchicine respectively. After 24 h, 
up to 50 % of the cell population appeared to be apoptotic and cell 
membrane preparations from both normal and apoptotic cells were 
carried out. The detection of novel proteins was approached by two 
different techniques: (i) subtractive immunization of mice for the 
generation of mAbs; and (ii) analysis of the whole protein profile 
from normal and apoptotic cells by 2D-PAGE.
ELISA-tests and flow cytometric analysis showed that only a small 
number of mAbs had been produced against apoptotic antigens from 
MCF-7 cells but not from HeLa or HL60 cells. However, silver- 
stained 2D-gels showed several proteins from all three cell types 
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" We are like the blind men who encountered an elephant : each of us 
had a different image [  of apoptosis ]  because we could not grasp 
the whole."
(modified from R.A. Weiss in Science 260: 1278, 1993)
1
1. INTRODUCTION
Cell death occurs in multicellular organisms via two distinct 
mechanisms termed necrosis and apoptosis. Both mechanisms are 
designed to remove cells from the organism which are no longer 
required in development or because they are damaged and could do 
harm to nearby healthy cells if they remain.
Necrosis eliminates great numbers of cells in response to an insult 
or injury suffered by the organism. This process does not require 
the expression of certain genes nor is it energy-dependent. Thus, 
necrosis is also referred to as passive or accidental death. 
Apoptosis selectively destroys cells during embryogenesis, meta­
morphosis, and tumor regression in order to maintain tissue 
homeostasis. It is also the regulatory mechanism in the negative 
selection of immunocompetent T-cells and the removal of virus 
infected cells. This form of cell death is an active process in 
which the cell itself participates. It requires the de novo 
expression of proteins and the activation of certain cell death 
genes. Therefore, apoptosis is often also called programmed cell 
death.
1.1 Necrosis
Necrosis is induced in cells damaged by an environmental insult or 
injury. The insult can be caused by exposure to a variety of toxic 
substances, respiratory poisons, hypoxia or lytic viral infection 
(Bowen & Bowen, 1990). In all cases the plasma membrane is either 
directly damaged or the membrane cation pumps fail to function as 
a result of a decrease in ATP levels due to a breakdown in mito­
chondrial ATP production. The greater permeability of the 
membrane results in an influx of Na+ and Ca2+ ions down the
2
concentration gradients into the cells. The intracellular accumula­
tion of these ions, further enhanced by impaired ion-pumps, leads 
to uptake of water and an increase in cell volume. At a certain 
point, the continuing increase in cell volume damages the 
organelles and the cell is no longer in a position to reverse the 
process. Protein synthesis decreases and the mitochondria start to 
swell. Further swelling of the cell finally ruptures the plasma 
membrane and the cell’s components are spilled into the 
surrounding tissue space causing an inflammatory response (Duvall 
& Wyllie, 1986). Necrosis can therefore be described as the result 
of the inability of a cell to maintain its volume.
Fig. 1: Morphological changes in apoptosis and necrosis (adopted from - 
Smith et al. 1993).
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1.2 Apoptosis
Apoptosis is a major regulator of tissue homeostasis during meta­
morphosis, embryogenesis, and tumor regression. It also plays a 
crucial role in immunity by the negative selection of T-cells during 
maturation. Compared to necrosis, apoptosis works in a more 
subtle way. A single cell is selected for death by an extracellular 
triggering event in the form of hormone or growth factor 
withdrawal or by binding of ligands to cell surface receptors. This 
signal is transduced via a number of pathways involving second 
messengers to the nucleus. Here, several so-called death genes are 
induced which either accelerate or inhibit the initiation of 
apoptosis. The involvement of special genes in this process has 
earned it the term programmed cell death. This also marks a key 
difference with necrosis - apoptosis requires energy and the active 
participation of the cell itself to carry out the whole process. In 
the nucleus a yet to be identified endonuclease is activated and 
cleaves the DNA at internucleosomal linker regions into lengths of 
200 bp and multiples of 200bp. At the same time a reduction in 
cell volume and condensation of the chromatin at the nuclear 
membrane occurs. Further decrease in cell volume causes blebbing 
of the plasma membrane. In the last stage, small vesicles 
(apoptotic bodies) are randomly formed containing organelles, 
cytoplasm, and nuclear fragments. The apoptotic bodies are 
recognized by macrophages and other phagocytic cells and 
phagocytosed (Gerschenson & Rotello, 1992; Raff, 1992; Cohen, 
1993; White, 1993).
Despite a greatly increased interest in apoptosis evidenced in the 
growing number of publications in the last ten years (Cohen, 1995),
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our knowledge and understanding of apoptosis is still very 
incomplete (Kerr, 1995). Progress has been hampered by 
differences in the behaviour of cells in vivo and in vitro 
(Earnshaw, 1995).
The biggest step toward a better understanding of apoptosis has 
been provided by studies into the genes involved in the regulation 
of apoptosis. The current data suggest that apoptosis is carried out 
by a complex system of pathways. The finding that the same cell 
can respond to different stimuli with different apoptotic 
pathways, makes the elucidation of the biochemistry of apoptosis 
even more difficult.
1.3. Signal transduction in apoptosis
1.3.1. Receptors involved in signal transduction in 
apoptosis
The generation of monoclonal antibodies against cell surface mole­
cules on human B-cells produced an antibody that recognizes the 52 
kD cell membrane protein APO-1 (Trauth et al., 1989). Treatment of 
a variety of cells with anti-APO-1 -antibody resulted in cell death 
by apoptosis (Debatin et al., 1990). Further studies by Dhein et al. 
(1992) demonstrated that apoptosis is initiated by the cross­
linking of the anti-APO-1-antibody to APO-1 cell surface antigens. 
In the same year Oehm et al. identified the APO-1 antigen as being 
homologous to the Fas antigen - a member of the TNF/NGF receptor 
family sharing homologys with the TNF receptor.
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Fig. 2 : The Fas/TNF/NGF receptor fam ily (adopted from Nagata, 1994).
The TNF receptor is also known for its ability to mediate apoptosis 
(Smith, 1994) and activates phospholipases, transcription factors 
(i.e. NF-kB), kinases and phosphatases (i.e. PKC) (Vandenabeele, 
1995). Some of these elements are involved in apoptosis and 
necrosis. Despite their sequence homologies, both molecules use 
different signalling pathways when mediating apoptosis. Schulze­
Osthoff et al. (1994) observed in studies with L929 fibrosarcoma 
cells that TNF kills by necrosis while APO-1 mediates apoptosis. 
However, in U937 cells apoptosis is mediated by both TNF and APO- 
1 (Schulze-Osthoff, 1994). In the case of TNF, the signalling 
pathway depends on the generation of reactive oxygen inter­
mediates (ROI) and ceramide (McConkey & Orrenius, 1994). In 
contrast, Fas/APO-1 requires an ICE-like protease for mediating 
apoptosis in rat fibroblasts (Enari et al., Los et al., 1995).
Data collected from research into autoimmune-diseases suggest 
that mutations in two gene loci can cause an autoimmune-disease
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to some extent. Mouse strains with severe autoimmune-diseases 
show a mutation in the Ipr locus (lymphoprolifération) or the gld  
locus (generalized lymphoproliférative disease) resulting in the 
production of a Fas/APO-1 receptor and ligand unable to mediate 
apoptosis. This enables double-negative T-cells to survive and also 
causes a B-cell defect resulting in the generation of auto­
antibodies (Nagata & Suda, 1995). Krammer et al. (1994) suspect 
that defective B-cells could be a side effect as B-cells are 
dependent on T-cells to generate antibodies against most antigens. 
A recent case study of five unrelated children suffering from the 
autoimmune-lympho-proliferative-syndrome (ALPS) revealed that 
this disease is caused by Fas gene mutations resulting in abnormal 
T-cell apoptosis (Fisher et al., 1995).
1.3.2 The involvement of calcium in apoptosis
It is an acknowledged fact that the divalent calcium cation plays 
an important role in many intracellular events from enzyme 
activation to cell volume control (Bowen & Bowen, 1990). 
Therefore, calcium has been suspected to be an important player in 
the regulation of apoptosis as well. The treatment of many cells 
with Ca2+-ionophores induced apoptosis in these cells. In many 
cases, treating cells with channel blockers or intra- and 
extracellular chelators inhibited apoptosis (McConkey & Orrenius, 
1994). It has been suggested that an increase in the intracellular 
calcium concentration is necessary to activate the endonuclease 
which degrades DNA (Wyllie, 1980). On the contrary, studies on 
human leukaemic HL60 cells show that elevated calcium levels in 
the cell are not necessary to induce apoptosis. Under virtually Ca2 + 
free conditions this cell type still undergoes apoptosis (Martin et
7
al., 1994). An influx of calcium is also a requirement to initiate 
necrosis as this action results in cell swelling (Bowen & Bowen, 
1990). Therefore, at this stage, changes in calcium concentration 
can be considered as associated with, rather than an initiator of 
apoptosis. The impact depends heavily on the concentration present 
in the cell and on the cell type. For example, the four different 
endonucleases reported as being involved in apoptosis are either 
dependent on, independent of, or inhibitable by high intracellular 
calcium concentrations (see 1.3.6).
1.3.3 Ceramide as a mediator of apoptosis
The phospholipid sphingomyelin, located in the plasma membrane of 
mammalian cells, is hydrolyzed through the action of sphingo­
myelinase, a sphingomyelin-specific form of phospholipase C, 
generating ceramide (Hannun, 1994). The hydrolysis of sphingo­
myelin into ceramide occurs upon stimulation of cell surface 
receptors such as the TNF- and the IL-1 receptor (Kolesnick & 
Golde, 1994), and the NGF- and Fas receptor (Wright & Kolesnick, 
1995). These receptors also play an important role in apoptosis. 
Studies show that increased levels of ceramide are found in TNF 
and Fas mediated apoptosis in certain cell types (McConkey & 
Orrenius, 1994). Other molecules, dexamethasone for example, also 
have an impact on the intracellular levels of ceramide. Pushkareva 
et al. (1995) proposed a scheme where ceramide acts a second 
messenger linking the mentioned cell surface receptors to the 
events of cell-differentiation, cell-cycle arrest, and apoptosis. In 
their scheme ceramide modulates the activity of several targets 
which in turn link ceramide to certain effectors causing either 
differentiation, cell-cycle arrest or apoptosis. Other pathways,
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including PKC for instance, may also be involved. However, more 
evidence in support of an involvement of ceramide in apoptosis 
still needs to be produced.
1.3.4 Oxidative stress as a mediator of apoptosis
Many of the agents, including gamma- and ionizing radiation, which 
are responsible for the induction of apoptosis are also capable of 
generating oxidative stress. All aerobic living cells use molecular 
oxygen as the terminal electron acceptor for oxidative phosphory­
lation. Oxygen also participates actively in many other metabolic 
processes. A side effect is the generation of reactive oxygen inter­
mediates (ROI), i.e. O2 " and OH*, which either damage macro­
molecules directly by stripping them of electrons or react with 
hydrogen peroxide, starting a chain reaction producing even more 
hydroxyl radicals. The attack of ROI is prevented under normal 
conditions by the distribution of antioxidants. The enzymes 
superoxide dismutase, catalase, and glutathione peroxidase act as 
ROI scavengers, while the agents tocopherol, carotenoids, and 
ascorbic acid block free radical chain reactions. Lactoferrin, 
caerulo-plasmin, and transferrin function as a source of free 
electrons. The balance between oxidants and antioxidants therefore 
determines the fate of a cell; survival or death (Borg, 1993).
Buttke and Sandstrom (1994) formed the hypothesis that oxidative 
stress would be a powerful tool for multicellular organisms to 
mediate apoptosis. They state that apoptosis can be induced either 
by the addition of ROI or the depletion of antioxidants. The addition 
of antioxidants would suppress apoptosis. Their statement finds
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support in results from a number of studies in recent years 
concerning HIV/AIDS.
Hirose et al. (1993) investigated the survival of tumour cells ex­
posed to IL-1, TNF, anticancer drugs, and ionizing radiation. They 
studied CHO cells and clones from the human melanoma cell line 
A375. Their results show that by overexpression of mitochondrial 
manganese superoxide dismutase (MnSOD) in these cells, the cells 
survive and recover from treatment with TNF, IL-1, and radiation. 
This treatment results in the generation of ROI which especially 
damages the DNA of mitochondria beyond repair and results in cell 
death. MnSOD is capable of scavenging the ROI, preventing the 
impact on the DNA.
The bcl-2  proto-oncogene product is known for its inhibitory 
effect on apoptosis in various cell types. It has been localized in 
nuclear membranes, endoplasmic reticula, and mitochondria (Kors- 
meyer, 1992). Mitochondrial membranes are a major production 
site for ROI because of the respiratory chain. Hockenberry et al. 
(1993) concluded that bcl-2 protects a cell from apoptosis via an 
antioxidant pathway. In their scheme bcl-2 functions "as a free 
radical scavenger serving as a nonreactive free radical trap". In 
this way, damage to the cell membrane in the form of lipid 
oxidation by ROI is inhibited. Their conclusion is based on work 
with bcl-2 deficient mice. These mice develop polycystic kidney 
disease and hypopigmentation because of cellular damage by lipid 
peroxidation.
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Results from recent studies in HIV-infection and AIDS suggest that 
oxidative stress plays an important role in the depletion of CD4+ 
T-cells, a major characteristic of AIDS (Levy, 1993). The trans­
cription factor NF-kB responds to high levels of hydrogen peroxide 
and is also activated by the apoptosis inducers IL-1 and TNF. NF-kB 
controls the transcription of immunologically important genes 
such as the major histocompatibility complex (MHC) genes and the 
c-fos gene and also controls the replication of HIV (Gougeon & 
Montagnier, 1993). HIV infected patients show high levels of 
plasma glutamate and low concentrations of plasma cystine and 
cysteine combined with decreased intracellular GSH (glutathione) 
(Droge et al., 1992). The antioxidant glutathione reduces hydrogen 
peroxide and is synthesized from cysteine. Cysteine is supplied 
from macrophages, based on their ability to transport cystine 
across the membrane and convert it into cysteine. This mechanism 
depends on the exchange with intracellular glutamate and is 
consequently inhibited by high plasma glutamate concentrations 
(Greenspan & Aruoma, 1994). In summary, the HIV-induced 
alterations which take place in infected T-cells results in a loss 
of antioxidant defense and in turn in a rise of ROI levels. High 
levels of intracellular ROI favor the replication of HIV and also 
have an important impact on the pathways initiating apoptosis by 
the activation of NF-kB.
Considering the damaging effect of ROI on cells, it is quite 
tempting to postulate a connection between ROI and apoptosis. But 
there is still no answer to the question what intracellular 
concentrations of ROI are required to initiate apoptosis. The 
impact of high ROI concentrations would be severe and result in
necrosis rather than apoptosis. The main target for ROI is the cell 
membrane where lipids are oxidized and phospholipases 
overactivated resulting in membrane blebbing, Ca2+ influx due to 
higher membrane-permeability and thus a loss of Ca2 + 
homeostasis. These features describe some of the events in 
necrosis. An important feature in apoptosis is the formation of 
apoptotic bodies. It is difficult to imagine in which way a severely 
damaged membrane is able to contribute to this process.
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1.3.5 The genetic regulation of apoptosis
1.3.5.1 Caenorhabditis elegans
During its development, the soil nematode Caenorhabditis elegans 
loses exactly 131 cells from a total of 1090 via apoptosis (Hen- 
gartner & Horvitz, 1994). Genetic studies revealed that 11 genes 
called ced genes (cell death abnormal) are responsible for the 
control of cell death in these cells (Osborne & Schwartz, 1994). 
Ced-3  and ced-4  are positive regulators of cell death and are 
expressed in all cells. Studies with null-mutations demonstrated 
that ced-9  is a negative regulator of cell death and interacts 
directly with ced-3  and ced-4 (Hengartner et al., 1992). Ced-9  
protects cells from cell death by inhibiting ced-3 and ced-4 while 
cells with a null-mutation in the ced-9  gene virtually all die by 
apoptosis. Ellis and coworkers (1991) showed that the ced-2, ced- 
5 and ced-10 genes are required for the engulfment of the dying 
cell. They also speculate that ced-1 and ced-8 are responsible for 
the expression of a specific marker in the dying cell which is 
recognized by a receptor on the engulfing cell expressed by ced-6 
and ced-7. This theory still needs to be confirmed. King et al. 
(1995) reports that ced-11 functions in a way which would support 
the integrity of apoptotic bodies. Sequence analysis of the ced-9  
gene discovered a 23 % homology to the bcl-2 proto-oncogene and a 
substantial similarity between the ced-3 protein product and the 
mammalian IL-1 B-converting enzyme (ICE) (Fanidi, 1994). Despite 
the progress in the elucidation of the death genes in C.elegans, 
little has been achieved to determine the function of death genes in 
mammalian cells. The next three tables give an overview of genes 
which are known to be expressed during apoptosis.
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table 1: Genes whose expression coincides with apoptosis
gene organism cell type function
ubiquitin moth muscle proteolysis
apolipoprotein III moth muscle lipid transfer
clusterin, SGP2 rat ventral prostate inhibit complement
c-fos rat ventral prostate transcription
c-m yc rat ventral prostate transcription
TGFß rat ventral prostate cell signalling
stromelysin mouse mammary gland proteinase
uPA mouse mammary gland protease
p53 mouse mammary gland tumour suppressor
tPA mouse mammary gland proteolysis
n u r-7 7 mouse T-cells transcription
egr-1 mouse T-cells transcription
transglutaminase rat liv e r protein crosslinker
cyclin D rat sympathetic neuron cell cycle control
table 2: Genes whose expression is required for apoptosis
gene organism cell type function
ced-3 nematode neurons phosphoprotein ?
ced-4 nematode neurons Ca-binding ?
p53 mouse T-cells irrad. ind. death
c-m yc mouse T-cells transcription
E1A Adenovirus mouse cell lines bind p53
table 3: Genes whose expression inhibits apoptosis
gene organism cell type function
ced-9 nematode neurons block apoptosis
p53 Baculovirus moth cell lines block apoptosis
1AP Baculovirus moth cell lines block apoptosis
bc l -2 mouse lymphoid block apoptosis
E1B Adenovirus mouse B-cell block E1A apoptosis
EBV-LMP1 Epstein-Barr virus human B-cell induce bcl-2
( table 1, 2 and 3 adopted from Schwartz/ Osborne, 1993)
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Besides the ced genes, at present the proto-oncogenes bcl-2 and 
c-m yc, and the tumour suppressor gene p53  are the best 
characterized genes involved in apoptosis in mammalian cells.
1.3.5.2 C-myc
C-myc encodes an unstable and short-lived DNA-binding protein 
called c-myc. It heterodimerizes with yet another protein termed 
max which is expressed by max (Amati & Land, 1994). Together 
they form a transcription factor executing control over cell growth 
and proliferation (Pawson & Hunter, 1994) as well as apoptosis 
(Harrington et al., 1994).
Shi et al. (1992) investigated the role of c -m yc  in T-cell 
hybridomas during activation induced apoptosis. They added c-myc 
antisense oligonucleotides to A1.1 and induced apoptosis with 
monoclonal antibodies to CD3 through the TCR. This action blocked 
apoptosis in these cells by causing a drop in c-myc levels. But 
Bissonette et al. (1994) reports that apoptosis induced by 
glucocorti-coids and cytotoxic agents is not affected by treatment 
with c-myc antisense oligonucleotides. He therefore suggests that 
c-myc is crucial only in some forms of apoptosis.
Other studies (Harrington et al., 1994) showed that c-myc induces 
apoptosis in growth factor deprived cells. An explanation for the 
ability of c-m yc  to induce either apoptosis or cell proliferation 
upon availability of growth factors resulted in the establishment 
of two models. In the conflict model, c-myc generates two signals. 
The signal mediated by mitogens leads to cell proliferation while 
the second signal, mediated by low serum or cytotoxic agents,
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results in apoptosis. The fate of the cell is based on a conflict of 
signals. In the dual signal model, apoptosis is inhibited by survival 
factors (i.e. growth factors and bcl-2). This means that cell pro­
liferation and apoptosis are coupled and that two independent 
signals are required for cell proliferation: one that activates cell 
proliferation and a second that suppresses apoptosis. Apoptosis 
occurs when the second signal is not present despite the existence 
of the first signal.
Fig. 3: M yc  induced apoptosis: two alternative models.
( adopted from Harrington et al., 1994 )
The dual signal model finds confirmation in the works of Fanidi et 
al. (1992) and Bissonette et al. (1992). In Chinese Hamster Ovary 
(CHO) cells and rat-1 fibroblasts bcl-2 interacts with c-myc and 
inhibits apoptosis but does not affect its ability to stimulate cell 
proliferation.
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1-3.5.3 The bcl-2  family
It was mentioned before that bcl-2 has significant homology with 
c e d -9  (Fanidi, 1994). It is assumed that b c l-2  is the main 
contributor to the survival of oncogenic cells by inhibiting 
apoptosis through the suppression of death signals (Fairbairn, 
1993). According to Korsmeyer (1992) and Akbar et al. (1993), the 
bcl-2  gene and its product probably play a crucial part in T-cell 
maturation and in the regulation of T-cell homeostasis after 
activation by antigen. The cells are directed either to apoptosis, 
low-level proliferation or to a quiescent state depending on the 
availability of growth factors i.e. IL-3 and fibroblast factor.
Recent studies show that bcl-2 interacts with a number of 
proteins whose genes share a homology of up to 21% (Nunez & 
Clarke, 1994). These protein-protein interactions may have a great 
impact on the regulation of apoptosis. Oltvai et al. (1993) and 
Korsmeyer (1995) demonstrated that bcl-2 heterodimerizes with 
bax and that both proteins also form homodimers. Overexpressed 
bax accelerates apoptosis in cells upon growth factor deprivation 
and also offsets the inhibitory effect of bcl-2 on apoptosis. A 
model has been established in which the survival of a cell or the 
execution of apoptosis after receiving the death signal depends on 
the current ratio of bax and bcl-2. An excess of bcl-2 allows the 
cell to survive while an excess of bax results in apoptosis.
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Fig. 4: Bcl-2, Bax and control of cell death, (adopted from Korsmeyer,1995)
B cl-x  is another bcl-2  related gene that has a positive and 
negative regulatory effect on apoptosis. This gene produces a large 
and a smaller mRNA coding for two proteins, bcl-xi_ and bcl-xs, 
with different functions. Boise et al. (1993) reported that bcl-X|_ is 
similar to bcl-2 in structure and also suppresses apoptosis. In 
contrast, bcl-xs has the ability to inhibit bcl-2 which results in 
apoptosis in growth factor deprived cells. High levels of bcl-XL are 
found in long-lived postmitotic cells while bcl-xs is overexpressed 
in cells with a high turn-over rate.
Yang and co-workers (1995) identified another bcl-2 related gene 
called bad. The bad-protein forms dimers with bcl-X[_ and bcl-2, 
but not with bax, bcl-xs or itself. It binds more strongly to bcl-X|_ 
by replacing bax than to bcl-2 and is able to inhibit the apoptosis­
suppressing ability of bcl-X|_ but not of bcl-2.
Yet another gene has been found in the human lymphoid cell line 
Jurkat named bag-1 (Takayama et al., 1995). Bag-1 is not related to 
bcl-2  but its protein binds to bcl-2. This results in enhanced
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protection from apoptosis by several stimuli. Cells which only 
showed elevated levels of one protein but not the other were not 
protected in such a way.
1.3.5.4 p5 3
The anti-oncogene or tumour-suppressor gene p53 is another gene 
whose product is involved in the regulation of apoptosis. It is 
assumed that the role of p53 is to arrest a damaged cell in the G1 
or G2-phase until the damage is repaired (Cohen, 1993). When the 
damage of the DNA is beyond repair, apoptosis is induced by p53. 
This means that p53 might act as a checkpoint for DNA damage
during the cell cycle (Strasser et al., 1994). Studies on null-
mutations in mice show that a loss of p53 results in the 
proliferation of cancer (Lane, 1993). Lowe et al. (1993) and Clarke 
et al. (1993) demonstrated that p53 is necessary for the induction 
of apoptosis in radiation damaged mouse thymocytes but not by 
glucocorticoids. Again, cells with null-mutations survived even 
under enhanced radiation. Recent studies by Miyashita and Reed 
(1995) discovered that the bax gene is a p53 primary response
gene. The bcl-2/bax ratio is important for the survival or
elimination by apoptosis of a cell. An excess of bax prepares a cell 
for apoptosis. A null-mutation in the p53  gene would directly 
influence the expression of bax. Thus, a (cancer) cell is even more 
likely to be protected against apoptosis.
1.3.5.5 ICE
The interleukin-1 (3 converting enzyme (ICE) is a cysteine protease 
which produces the active form of proinflammatory cytokine IL-1(3 
from its precursor. The homology to the ced-3 product, which is
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involved in the regulation of apoptosis in C. elegans, predicts an 
association in apoptosis (Kumar, 1995). Enari et al. (1995) and Los 
et al. (1995) report that an ICE-like protease is involved in Fas 
mediated apoptosis in rat-1 and rat-2 fibroblasts. The action of 
ICE is inhibited by the overexpression of the crmA gene. Enari et al. 
propose the generation of the ICE-like protease from a precursor 
upon a signal from Fas or the inactivation of the crmA product. In 
addition, Miura et al. (1993) report the inhibition of ICE by bcl-2. 
Conversly, Li et al. (1995) state that ICE has no function in 
apoptosis. They created ICE deficient mice whose thymocytes and 
macrophages execute apoptosis normally. Kumar (1995) suspects 
the involvement of more than one protease in apoptosis, so that the 
elimination of one form has no effect.
The current knowledge of the genetic regulation of apoptosis 
suggests:
• more than one pathway executes apoptosis
• different stimuli activate different pathways in the same cell
• apoptosis is closely related to proliferation and differentiation
• one cause for cancer is the inability of the cell to undergo 
apoptosis
1.3.6 DNA fragmentation
The collapse of the nucleus and the enzymatic degradation of the 
DNA followed by chromatin condensation is one of the first visible 
structural changes of a cell undergoing apoptosis. Internucleosomal 
DNA degradation occurs by activation of an endogenous endo­
nuclease that cleaves the DNA in the unprotected linker region bet­
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ween the nucleosomal histones on the chromosomes. The DNA is 
wrapped around the histones in loops spanning approximately 180­
200 bp in length. Consequently, an electrophoretic separation of 
extracted DNA on gels results in the formation of the so-called 
apoptotic ladder - multiples of about 200 bp in length. This was 
first demonstrated by Wyllie (1980) in rat thymocytes and soon 
became recognized as a hallmark of apoptosis. In the past, several 
attempts have been made to characterize and identify the 
endonucleases taking part in apoptosis. At least four endonucleases 
have been indicated, although final proof still needs to be produced 
(Bortner et al., 1995).
Thymocytes treated with dexamethasone and IL-2 dependent CTLL2 
cells upon IL-2 deprivation, die by apoptosis. In both cell types 
endonuclease activity was observed resulting in the degradation of 
DNA typical for apoptosis. They were identified as NUC-18 (Peitsch 
et al., 1994), and NUC-40 and NUC-58 (Deng et al., 1993), based on 
their molecular masses of 18, 40 and 58 kDa. All three enzymes are 
dependent on both Ca2+ and Mg2+ ions, and can be inhibited by Zn2+ 
ions. The optimal pH for the DNase activity lies in the range of pH 
7-8. While NUC-58 is primarily found in the cytoplasm, NUC-18 and 
NUC-40 are localized in the nucleus. It is believed that all three 
enzymes are not synthesized in response to dexamethasone or upon 
IL-2 deprivation but rather are activated by another protein or 
enzyme induced by such a treatment. Deng and Podack (1993) 
suspect the existence of DNase precursors undergoing proteolytic 
alterations which in turn initiate DNase activity.
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Ribeiro and Carson (1993) purified an endonuclease from human 
spleen nuclei, that is dependent on Ca2+ and Mg2+ ions and is 
inhibited by Zn2+ and high Ca2+ concentrations. The enzyme has a 
pH optimum of 8.0 and digests the chromatin of endonuclease- 
lacking CCRF-CEM lymphoblast nuclei to produce an 'apoptotic 
ladder1. On the basis of these findings they suggest that this 
endonuclease is involved in apoptosis. Nuclei from apoptotic human 
spleen cells were not investigated. They speculate that this 
enzyme is activated during apoptosis by a drop in the intracellular 
Ca2+ concentration. This stands in contradiction to other studies 
showing that a rise of the intracellular Ca2+ level precede DNA 
degradation (McConkey et al., 1989).
DNase I has been proposed as another strong possibility for an 
apoptotic endonuclease (Bortner et al., 1995). This enzyme requires 
Ca2+ and Mg2+ ions and operates in a pH range from 5.5 to 9.0. 
These data resemble those from other putative apoptotic endo­
nucleases. However, DNase I only produces single-stranded breaks, 
whereas at least one unrepaired DNA double-strand break is 
sufficient to kill a cell (Barry/ Eastman, 1992). A signal peptide in 
the DNase I protein leads to extracellular secretion resulting in 
high serum concentrations. Therefore, DNase I only gets into 
contact with DNA through a ruptured nuclear membrane under 
necrotic conditions. These facts disqualify DNase I as an apoptotic 
endonuclease.
Barry and Eastman (1992) identified DNase II as an endonuclease 
involved in apoptosis in CHO cells. This enzyme is not dependent on 
Ca2+ or Mg2+ ions and becomes activated by a pH drop from 7.0 to
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6.5. Although they admit that only the cytoplasmic pH was 
measured and not the intranuclear pH, they argue that an H+- 
ATPase in the nuclear membrane maintains a pH lower on the inside 
of the nucleus compared to the cytoplasm. This acidic pH would 
then be sufficient to activate DNase II during apoptosis. But they 
do not discuss how the DNase II gets into the nucleus. Final proof 
for DNase II being an apoptotic endonuclease still has to be 
produced.
DNA degradation during apoptosis is one of the earliest changes 
which can be observed. Therefore it was considered as one of the 
main causes for cell death. Different cell types die by apoptosis in 
response to different stimuli. It is reasonable then to suggest that 
different endonucleases are activated to digest the DNA. The 
digestion of DNA is unquestionably carried out to prevent DNA of 
cellular and viral origin from circulating in the bloodstream and 
presenting the possible danger of transfecting healthy cells. 
However, it is still not clear whether DNA degradation is a causal 
event in apoptosis or simply a clean up process not directly 
initiating cell death.
1.3.7 The formation of apoptotic bodies and their recogni­
tion by phagocytes
The purpose of apoptosis is to remove cells. The final stage in this 
process is the breaking up of the cell into a number of small 
vesicles termed apoptotic bodies. These apoptotic bodies contain 
the DNA fragments, organelles, and cytoplasm of the disintegrated 
cell. The containing of the cell's intracellular components prevents 
spillage into extracellular tissue space which in turn would cause
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an inflammatory response. The apoptotic bodies are recognized by 
macrophages and other phagocytotic cells and removed.
Transglutaminases form a group of Ca2+ dependent enzymes 
functioning to cross-link proteins by generating e(y-glutamyl) 
lysine bonds and by incorporating amines into the plasma 
membrane. The result is a stable network of polymerized proteins 
resistant to breakage and chemical attack. The destruction of these 
polymers is only possible after proteolysis of the protein chains 
(Folk, 1980). Activity of these enzymes can only be detected in 
non-dividing cells with terminated differentia tion. In 
kératinocytes, a transglutaminase is activated specifically using 
substrates like involucrin, loricrin, actin, and others for cross­
linking. The stabilizing effect on the dying kératinocyte is the main 
reason for the skin's stability (Piacentini et al., 1994).
Fesus et al. (1987) found elevated levels of tissue transgluta­
minase mRNA in hepatocytes during apoptosis. Tarcsa et al. (1992) 
confirmed this and showed that in dog hepatocytes an involucrin- 
like protein is used as a substrate by tissue transglutaminase for a 
cross-linking reaction. It becomes incorporated into the apoptotic 
bodies and is the main contributor to their stability. Recent 
studies by Zhang et al. (1995) investigated the involvement of 
retinoids in the regulation of transglutaminase II and apoptosis. 
Their results show that in the rat tracheobronchial epithelial cell 
line SPOC-1, transglutaminase II gene expression is activated in 
retinoid induced apoptosis. Both actions are mediated by the 
retinoid signalling pathway including the RARa-receptor. These 
data represent a good example of the upregulation of gene
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expression in apoptosis. Transglutaminases are acknowledged as a 
major contributor to the stability of apoptotic bodies. But the 
details of the actual process of formation of apoptotic bodies are 
still unknown.
Macrophages clearing tissue of apoptotic bodies have to distinguish 
between normal cells and apoptotic bodies. Apoptotic cells signal 
their 'edible status' by changes on the surface of their membrane 
which are recognized by macrophages and other phagocytotic cells. 
Studies on thymocytes (Morris et al., 1984; Duvall et al. 1985), 
aging human neutrophils ( Savill et al., 1989 (a)(b)) and lympho­
cytes ( Savill et al., 1990; Fadok et al., 1991) led to the proposal of 
three recognition mechanisms.
Fig. 5: Proposed recognition mechanisms for phagocytes and apoptotic  
cells, (adopted from Savill et al., 1993)
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Lectins are well known as cell recognition molecules binding to 
cell surface carbohydrates virtually throughout all kingdoms of the 
living world (Barondes, 1988; Drickamer, 1988; Sharon & Lis, 
1989). Duvall et al. (1985) demonstrated that binding of 
macrophages to apoptotic thymocytes occured to a lesser extent 
when certain aminosugars (i.e. N-actylglucosamine) were added. 
However, aminosugars do not inhibit the phagocytic uptake of 
apoptotic neutrophils and lymphocytes. This process is mediated 
via the vitronectin-receptor integrin corresponding to 
thrombospondin, secreted by the macrophage, and the CD36 ligand 
on the macrophage (Savill et al., 1990). Phosphatidylserine, 
normally located on the cytosolic side of the membrane, is moved 
to the outside for exposure by the enzymes translocase and 
scramblase, whose activity is reportedly increased during 
apoptosis (Schroit et al., 1985; Fadok et al., 1991; King et al., 
1995). Fadok et al. (1992) demonstrated that different populations 
of macrophages recognize either the vitronectin receptor or 
phosphatidylserine on apoptotic cells regardless of the species or 
type of cell. It seems that apoptotic cells share apoptotic markers 
and that these markers are determined by the subpopulation of 
macrophage mediating the uptake.
However, this implicates the interaction of the macrophages with 
the dying cell at an early stage of apoptosis to allow the cell to 
express the markers. This raises the question of whether 
chemoattractants are involved in recruiting phagocytes to the site 
of apoptosis. Human malignant cells, for instance, use low 
molecular size proteins as chemoattractants for the recruitment
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of monocytes and macrophages (Graves et al., 1989). A similar 
action for apoptotic cells has not been confirmed yet.
1.3.8 Cancer and apoptosis
A main characteristic of cancer is the uncontrolled growth of cells 
(Kamb, 1995). Apoptosis on the other hand, is the organism's most 
effective tool to keep cell-turnover under control. Therefore it has 
been suggested that apoptosis is impaired in these cells. The 
protooncogene p53 for example, plays an important role in the 
regulation of apoptosis (Sen/D'lncalci, 1992). p53 is a tumour 
suppressor gene that acts as a cell-cycle-checkpoint DNA damage- 
the cell is kept in the G1 or G2-phase for repair or apoptosis is 
induced (Schwartz/ Osborne, 1992). In many cases cancer cells 
have a mutation or deletion in the p53 gene which explains the 
resistance of many cancer cells to radiation treatment. In mouse 
thymocytes, radiation induced apoptosis is dependent on p53  
(Lowe, 1993). But Clark et al. (1993) and Strasser et al. (1994) 
demonstrated the induction of apoptosis in cells via a p 5 3  
independent pathway. Fisher (1994) suspects the different path­
ways inducing apoptosis in a cell upon different stimuli being the 
main reason for the resistance of cancer cells to treatment. In his 
opinion, this makes different cell types more or less susceptible to 
apoptosis and thus to anticancer treatment. The usual anticancer 
treatments kill cancer cells by impairing their metabolic pro­
cesses. Inducing apoptosis in a cancer cell would provide a more 
efficient way in anticancer treatment but this requires the 
knowledge of the most efficient pathway to induce apoptosis.
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1.3.9 Apoptosis in the immune system
A normal human body contains approximately 5I of blood with a 
total lymphocyte population of about 10 billion cells. During an 
infection the number of lymphocytes increases between 4 to 15 
times in the blood. Apoptosis is an important factor in the immune 
response by the negative selection of autoreactive or mis- 
constructed receptor bearing lymphocytes. Another important role 
is the reduction of the number of lymphocytes and the 
establishment of memory cells after a successful antigen defence 
(Akbar & Salmon, 1995).
B- and T-cells are generated in the bone marrow from a pluripotent 
stem cell. Their precursors then develop antigen receptors, B-cells 
in the bone marrow and T-cells in the thymus. T-cells with 
autoreactive or misconstructed receptors are removed by the 
induction of apoptosis via the TCR-CD3 complex (Cotter et al., 
1994).
The surviving lymphocytes, guaranteeing self tolerance, enter the 
bloodstream and circulate until they encounter antigens. Upon 
recognition of the antigen by the lymphocyte, a rapid increase of 
the lymphocyte population by producing clones is observed. During 
an ongoing immune response, T-cells are constantly activated by 
antigen to undergo repeated cycles of cell division. They are 
further stimulated by the cytokine IL-2, synthesized by CD4+ T- 
cells. The continuous expansion of the clonal population results in 
a reduced expression of the apoptosis inhibitor bcl-2 and the 
increased expression of the apoptosis inducer Fas, making B- and 
T-cells more susceptible to apoptosis.
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The immune response finally eradicates the antigen and terminates 
the activation of T-cells and CD4+ T-cells, with the consequence 
of limited levels of IL-2. Following this, most of the T-cells die by 
apoptosis because of cytokine depletion and propably also by Fas­
ligand interactions (Kroemer & Martinez, 1994; Kroemer 1995).
In the lymphoid tissue, selection of B- and T-cells with the highest 
affinity for the antigen takes place to secure the memory pool. 
Activated B-cells bind to the antigens presented by dendritic cells 
in lymph node structures termed germinal centers. The B-cells 
with inappropriate antigen recognition die by apoptosis. The B- 
cells with high affinity surface immunoglobulins either differen­
tiate into plasma cells upon IL-1 and CD23 activation and produce 
antibodies, or they present antigen on the surface (MHC) inter­
acting with T-cells. The T-cells in turn expresses the ligand to the 
CD40 molecules present on the surface of the B-cells. This action 
prevents the B-cells from apoptosis and makes them memory cells. 
The result is the retainment of highly competent B- and T-cells 
(Krammer et al., 1994).
The immune response against antigen is carried out by T- and B- 
cells. Virally infected, tumour, and allogeneic cells are removed by 
cytotoxic T lymphocytes (CTL) and natural killer (NK) cells. They 
kill any cell their receptor binds to (Martz & Howell, 1989). The 
interaction between CTL/NK and the target cell results in cell 
death similar to the morphology of apoptosis (Cohen, 1992).
CTL kill their target cell by two mechanisms - the secretory 
pathway mediated by perforin and granzyme, and the non-secretory
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pathway mediated by Fas-receptor-ligand interaction. Both path­
ways result in the death of the cell by DNA fragmentation (Vaux et 
al., 1994).
During the secretory pathway, CTL and NK cells approach close to 
the target cell and release perforin from cytoplasmic granules into 
the space between the cells. Perforin creates pores between 12 and 
20 nm in diameter in the target membrane (Liu et al., 1995), which 
allows granzymes secreted from CTL/NK cells to enter the cyto­
plasm of the target cell (Tschopp & Nabholz, 1990). Granzymes are 
proteinases which are suspected to induce apoptosis by generating 
ICE from its precursor (Smyth & Trapani, 1995). This action results 
in the fragmentation of the DNA in an apoptotic manner, but with 
different kinetics - CTL-killing occurs within minutes while it 
takes hours upon growth factor deprivation (Cohen et al., 1992).
The non-secretory pathway triggers apoptosis by crosslinking of 
the Fas-receptor on the target cell with ligands on the CTL. Studies 
on Ipr mice with perforin-free CTLs support this theory (Berke, 
1995).
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1.3.10 Apoptosis and viruses
Many viruses regulate either positively or negatively apoptosis in 
their host cell. The inhibition of early apoptosis in an infected cell 
gives the virus sufficient time for maximum replication. The 
induction of apoptosis is useful when an apoptotic transcription 
factor also controls viral replication (HIV). Viruses modulate 
apoptosis with proteins similar to the apoptotic proteins normally 
generated by a cell, i.e. bcl-2. The viral apoptotic proteins are 
encoded by genes on the viral genome (Shen & Shenk, 1995).
1.3.10.1 The Adenovirus
Adenoviruses express three proteins to block apoptosis in the host 
cell, called E1A, E1B-19kDa and E1B-55kDa. The E1A protein 
stimulates cell growth by driving the cell into the proliferative S- 
phase of the cell cycle. This action alone would result in early 
apoptosis of the cell, because E1A also induces the apoptosis 
mediator p53. It is suspected that then the E1B-55kDa protein 
binds directly to p53 and thus blocks its transcription. The E1B- 
19kDa protein is probably involved in a signal transduction path­
way due its localization to nuclear and cytoplasmic membranes 
(White & Gooding, 1994).
1.3.10.2 The Epstein-Barr-virus (EBV)
The Epstein-Barr virus (EBV) infects circulating human B-cells. But 
most of the B-cells die by apoptosis after an infection and only a 
small number of cells survive as memory cells. EBV therefore 
either has to encounter the small number of memory B-cells or 
must inhibit apoptosis in the circulating B-cells. Apparently, EBV 
inhibits apoptosis in B-cells by the upregulated expression of bcl-
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2 even under growth factor depleted conditions. This is mediated 
by the expression of eight virus-coded latent proteins. Henderson 
et al. (1991) demonstrated that the latent membrane protein 1 
(LMP1) is responsible for the upregulation of the bcl-2 expression.
1.3.10.3 The human immunodeficiency virus (HIV)
The main characteristic in HIV-infection is the depletion of CD4+ 
T-cells which finally results in AIDS (Levy, 1993). It was 
described before that HIV infected T-cells die via apoptosis 
mediated by oxidative stress. However, this does not explain the 
apoptotic death of non-infected T-cells in HIV patients. The vast 
majority of dying T-cells belongs to the non-infected group. This 
suggests that apoptosis is somehow induced from the outside by 
HIV. Research over the last years resulted in the establishment of 
three models (Ameisen & Capron, 1991; Ameisen, 1992; Weiss, 
1993; Gougeon & Montagnier, 1993; Ameisen et al., 1995):
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Fig. 6: The crosslinking of CD4 to the env protein.
( adopted from Ameisen et al., 1995)
T h e  C D 4 m o le cu le  on the  su rfa ce  of the un in fe c te d  CD4+ T -ce ll is 
c ro s s lin k e d  to the  gp160  or gp120  H IV  enve lope  prote in  (env). The 
e n v  p ro te in  is e x p re s s e d  on th e  s u r fa c e  o f H IV  in fe c te d  
m a c ro p h a g e s  o r C D 4+ T -ce lls , o r are p re se n te d  by n o n -in fe c tio u s  
p a r t ic le s  on  d e n d r it ic  c e lls  o r in c o m p le x e s  w ith  a n t i-e n v  
a n tib o d ie s . T h e  c ro s s lin k in g  in d u ce s  a p o p to s is  in the  u n in fe c te d  
C D 4 +  T -ce ll and p ro b a b ly  invo lves cy to p la sm ic  k inases.
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Fig. 7: The crosslinking of CD4 to the env protein and Fas 
action, (adopted from Ameisen et al., 1995)
S im ila r  to  Fig. 6, the  C D 4 m olecu le  on n o n -in fe c te d  CD4+ T -ce lls  is 
c ro s s lin k e d  to  the  e nv  p ro te in  exp re sse d  by H IV in fec ted  ce lls  and 
c o m p le x e s  w ith  a n ti-e n v  a n tib o d ie s . T he  s e c re tio n  of the H IV  T a t 
re g u la to ry  g ene  p ro d u c t in d u ce s  the  e x p re s s io n  of Fas and F a s ­
lig a n d  in u n in fe c te d  T -c e lls . The  F a s -lig a n d  p ro d u c in g  ce lls  th e n  
in it ia te  a p o p to s is  in th o se  ce lls  e xp re ss in g  the  Fas an tigen .
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Fig. 8: TCR mediated apoptosis, (adopted from Ameisen et al., 1995)
An u n in fe c te d  C D 4+ T -ce ll b e co m e s s u s c e p tib le  to a p o p to s is  as 
d e sc rib e d  in Fig. 6. The so prim ed un in fec ted  T -ce ll is then induced 
to  u n d e rg o  a p o p to s is  by an H IV -in fec ted  m acrophage  in response  to 
fa ile d  T C R  s tim u la tio n . T -ce ll d iffe re n tia tio n  is d e p e n d e n t on c o ­
s t im u la t io n  w ith  c y to k in e s  a n d  T C R  s t im u la t io n  by a n tig e n  
p re s e n tin g  c e lls . T h e  in fe c te d  m a c ro p h a g e  se c re ts  the a p o p to s is  
p ro m o te r  IL -1 0  w h ile  the  e xp re ss io n  of the  a p o p to s is  in h ib ito r  IL- 
12 is im p a ire d ; it a lso  fa ils  to  e x p re ss  the  B7 m o le c u le  w h ich  
f in a lly  re s u lts  in a p o p to s is .
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1-4 The aims of this study
This study aims to investigate the expression of proteins in cell 
membranes of cells undergoing apoptosis. These 'apoptotic' pro­
teins may be proteins which are newly expressed during apoptosis, 
those whose expression is upregulated during apoptosis, or 
proteins which undergo post-transcriptional alterations during 
apoptosis.
Possible roles for 'apoptotic1 proteins in apoptosis would be as 
enhancers in signal transduction pathways, markers on the cell 
surface for phagocyte recognition, or enzymes involved in 
secondary reactions, i.e. scramblase and translocase. These 
functions would predict a location mainly in the cell membrane.
In order to demonstrate that proteins are expressed specifically 
for the process of apoptosis, the following strategy was designed:
(i) the generation of monoclonal antibodies against 'apoptotic' 
proteins by subtractive immunization of mice;
(i i ) analysis of the whole protein profile by 2D-PAGE;
The studies were carried out on cells from the human HeLa, HL60, 
and MCF-7 cell lines.
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2. MATERIALS & METHODS
2.1 Chemicals and solutions
Bis-acrylamide and SDS were purchased from BDH; Biolyte 3/10, 
5/7 and 5/8 from BioRad; Coatasil from Ajax; FCS and DMEM : F12 
from BioSciences; DÎT from Boehringer/ Mannheim; NP-40 from 
Fluka Biochemika; and APS, BCA, BSA, colchicine, cyclo­
phosphamide, 6-DMAP, DMSO, EDTA, FCA, FIA, glycine, Hepes, 
hydroxyurea, okadaic acid, PMSF, TEMED, and Tris from Sigma.
PBS: 8.0 g /l 
0.2 g /l 
0.2 g /l 






Heat denatured casein (HDC): 1% (w/v) casein sodium is dissolved
in PBS at 65-70 °C
FACS-FIX: 1% (w/v) paraformaldehyde flakes are dissolved with 
heat in PBS, adjusted to pH 7.4
2.2 Cell lines
HeLa : human epitheloid carcinoma 
HL60: human monoblastoid
MCF-7: human breast cancer
2.3 Tissue culture




(ATCC = American Type Culture Collection)
growth medium:
1 2 g /i DMEM : F12
4.67 g / i Hepes
0.85 g / i NaHC03
in milliQ-water adjusted to pH 7.2 and 
filter (0.2 jim) sterilized
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2.3.2 Cell culture
The cell lines were maintained in DMEM : F12 growth medium sup­
plemented with 10% FCS. The incubation was carried out at 37°C in 
a humidified 10% CO2 atmosphere in a Forma Scientific incubator.
2.3.3 Induction of apoptosis
Apoptosis was induced by the addition of 15 nM okadaic acid from a 
1000x concentrated stock made in DMSO to MCF-7 cell cultures and 
2 pM of colchicine from a 100x concentrated made in DMSO to HL60 
cell cultures. HeLa cell cultures were first exposed to 2.5 mM 
hydroxyurea from a 100x concentrated stock made in DMSO. After 
5h of incubation, the whole medium was replaced by new, freshly 
sterilized growth medium containing 5 mM 6-DMAP. All cell 
cultures were observed under a light microscope at 0, 12 and 24 
hours after addition of the apoptosis inducers. After 24h the cells 
were collected for the membrane preparation. Cells from the 
adherent growing HeLa and MCF-7 cell lines remaining attached to 
the surface of the flask were dislodged by brief incubation with 
with PBS, diluted 1:1 in milliQ-water, containing 5mM EDTA.
2.4 Preparation of the total cell membrane fraction
(modified from Graham, 1993)
2.4.1 Buffers





• wash buffer: standard PBS + 5mM EDTA, pH 7.4
2.4.2 Method
2 x 108 cells were centrifuged in 50ml Falcon tubes for 5 min at 
1600 rpm. The supernatant was discarded and the cell pellets were 
resuspended in a small volume of PBS. All suspensions were then 
transferred into a single Falcon tube to obtain a single pellet. The 
tube was topped up with PBS and spun again at 1600 rpm for 5 min. 
The washing with PBS was repeated twice. The supernatant was
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poured off and the pellet resuspended in 10 ml of ice-cold 
hypotonic lysis buffer and allowed to stand on ice for 20 min. This 
was followed by sonication on ice for 3-5 x 20 sec bursts on high 
setting. The suspension was inspected under a light microscope to 
confirm the effective disruption of the cells. Sonication was 
repeated if whole cells were still found. The suspension was then 
centrifuged for 5 min at 2000 rpm at 4°C in order to pellet 
mitochondria, nuclei, and other large fragments. The supernatant 
was then transferred to 50 ml high-speed tubes and centrifuged for 
30 min at 20000 rpm and 4°C in a Beckman J2MC Centrifuge in 
order to pellet the total membrane fraction. The supernatant was 
discarded and the pellet resuspended in cold wash buffer and then 
briefly sonicated on ice. The tube was then topped up with wash 
buffer and centrifuged again for 30 min at 20000 rpm at 4°C. The 
pellet was resuspended in 1 ml cold PBS/ EDTA and briefly 
sonicated. Finally, the membrane suspension was transferred to a 
cryovial and stored in liquid nitrogen at -180°C until further use.
2.5 Bicinchoninic acid (BCA) micro protein assay
(modified from Smith et af., 1985)
2.5.1 Reagents •
• reagent A: 8% (w/v) Na2C03/ H20
1.6% (w/v) NaOH
1.6% (w/v) Na2 -tartrate
pH 11.25
• reagent B: 4%(w/v) Na2-BCA in milliQ-water
• reagent C: 4 vol of 4% (w/v) CUSO4/ 5 H2O plus 100 vol B
• reagent WR: 1 vol of reagent A + 1 vol of reagent C
The reagents A, B and the CuSC>4 -solution are stored at room 
temperature while the reagents C and WR were freshly made prior 
to use. BSA standards ranging from 5-100 |iig/ml was made from a 
concentrated stock (1 mg/ ml) in PBS.
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2.5.2 Method
Duplicate BSA standards and binary protein sample dilutions were 
set up in a clean ELISA tray. 100 pi of standards and samples were 
added to each well followed by 100 pi of WR. The cellotape sealed 
ELISA tray was then incubated for 30 min at 60°C. After removing 
the cellotape, the tray was read at room temperature and A 595 
nm. Protein concentrations were estimated by interpolation from 
the BSA standards.
2.6 Solubilization of membrane proteins
Three mg of membrane protein was resuspended in 20pl 0.5 M Tris- 
HCI (pH 6.8), 40pl 10% (w/v) SDS, 1pl 0.1 M MgCI2, 2% (w/v) DTT, 
and 139 pi milliQ-water. The suspension was heated for 30 min at 
70°C and then centrifuged for 60 min at 40000 x g in a Beckman 
TL-100 Ultracentrifuge. After centrifugation, the supernatant was 
collected and transferred into cryovials and stored in liquid 
nitrogen at -180°C until further use.
2.7 Generation of antibodies
2.7.1 Subtractive immunization (modified from Brooks et al., 1993)
This method is designed to improve the chance of generating mAbs 
for rare antigens from complex tissue extracts. Tissue extracts 
that share common (normal) antigens but do not share the rare 
(apoptotic) antigens are used. First, the tissue extract containing 
only the common (normal) antigens is administered together with 
the immuno suppressant drug cyclophosphamide. This drug ter­
minates the immune response to the common (normal) antigens. 
After recovery, the tissue extract which also contains the rare 
(apoptotic) antigens is injected. Because of the pre-treatment 
with cyclophosphamide, mAbs are generated primarily against the 
rare (apoptotic) antigens and not against the common (normal) 
antigens both tissue extracts share (Matthew/Sandrock, 1987).
Six female Balb/c mice per cell line, 6 weeks old and 18-22g of 
weight, were injected intraperitoneally (i.p.) on day 1 with a total 
volume of ca. 0.2 ml containing ca. 50pg of cell membrane proteins
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from healthy HeLa, HL60 and MCF-7 cells in sterile PBS and 
emulsified 1:1 with FCA. On day 2 and 3 each mouse received an 
injection of 200mg cyclophosphamide/ kg mouse in 0.2 ml of 
sterile PBS. On day 24, the mice were inoculated i.p. with ca. 50jig 
of cell membrane proteins from apoptotic cells in sterile PBS 
emulsified 1:1 with FCA. The second immunization took place on 
day 38. The same amount of apoptotic proteins were administered 
but emulsified with FIA. On day 42, sera were collected and 
analyzed by ELISA for reactivity to apoptotic antigen. The mice 
received a final boost of ca. 50jig of apoptotic proteins in sterile 
PBS on day 52 and were then sacrificed on day 60.
2.7.2 ELISA
The screening for antibodies against apoptotic antigens was 
carried out on 96-well-ELISA plates. The wells were coated and 
then blocked with HDC/PBS. Each incubation step was 1h at 37°C 
and was followed by washes with PBS for 4 times on a plate 
washer.
The first antibody was blood serum diluted 1:100. HRP conjugated 
sheep-anti-mouse Ig, diluted 1:2000 in HDC, was applied as the 
second antibody. OPD in 0.05 M citrate/0.1 M phosphate (0.03% 
(v/v) hydrogen peroxide) was used as substrate. The reaction was 
stopped by the addition of 50 jul 0.1 M HCI to all wells. The 
absorbances were determined at 450nm on a BioRad Model 3550 
Microplate reader.
In a second experiment, the same conditions were applied as before 
except the second antibody. The HRP conjugated sheep-anti-mouse 
Ig was replaced by a biotin conjugated sheep-anti-mouse Ig diluted 
1:2000. Then a streptavidin/HRP-biotin complex, 2.5 jig/ml of each 
in HDC, was added followed by the same procedures as before.
2.7.3 Depletion of antibodies reactive with normal 
antigen
2 x 108 cultured healthy MCF-7 cells were split up into three 
aliquots and centrifuged for 5 min at 1600 rpm to form three cell 
pellets. The supernatant was discarded and the first cell pellet 
was resuspended in MCF-7 mouse antiserum, diluted 1:100. After
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30 min of incubation at room temperature with gentle rocking, the 
suspension was centrifuged again. The supernatant was collected 
and used to resuspend the second pellet under the same conditions. 
The same procedure was carried out with the third pellet. The 
supernatant obtained from the third incubation was used to 
resuspend a pellet of 5 x 107 apoptotic cells under the same 
conditions.
FACS-analysis
The cell pellets from the healthy cells primed with antibodies (i.e. 
mouse anti serum), were resuspended with the second antibody, 
sheep-anti-mouse-lg-FITC, diluted 1:50 in BSA/PBS/Az, and 
incubated on ice for 30 min protected from light. The suspension 
was then washed with ice-cold PBS/Az and centrifuged. The cell 
pellets were resuspended in FACS fix and then analyzed on a Becton 
Dickinson FACSort flow cytometer by using the FSC and SSC 
signals. The same procedure was carried out with the apoptotic 
cells.
2.8 2D-Page (modified from O’Farrell, 1975)
2.8.1 First dimension IEF tube gels
2.8.1.1 Solutions •
• detergent solution: 0.3 9 CHAPS
100 H I NP-40
900 ILL I dd water
• gel monomer solution: 1 1 g urea
3 ml acrylamide/ bis-acrylamide
0.2 m I Biolyte 3/10
0.8 ml Biolyte 5/8
1.0 m I detergent solution
dd water is added to a final 
volume of 20ml
• upper running buffer: 20 mM NaOH in milliQ-water
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• lower running buffer: 10 mM H3PO4 in milliQ-water
• sample preparation: solubilized protein is diluted 1:3 with
9.5 M urea
2 % (w/v) ampholines
2 % (w/v) DTT
8 % (w/v) NP-40
2.8.1.2 Gel preparation
Urea was dissolved in acrylamide/bis-acrylamide and an equal 
amount of milliQ-water with gentle heating (< 4 5 °C). Depending on 
the desired pH-gradient, the ampholytes were added in various 
ratios. Finally, the detergent solution and milliQ-water was added. 
The solution was mixed and degassed. 20jil TEMED and 40|llI 10% 
(w/v) APS were added to the solution prior to gel casting. The gels 
were cast in 18 cm long capillary glass tubes with an inside 
diameter of 1.5 mm. The glass tubes were coated with Coatasil* on 
the inside. Each capillary glass tube waqs connected to a syringe at 
the top and inserted into a test-tube filled with 1 ml of 
acrylamide solution. The solution is then pulled up to the 14 cm 
mark by using the syringe and allowed to polymerize for 2 h.
(* 2% dimethyldichlorosilane in 1.1-trichloroethane)
2.8.1.3 Running the first dimension
The capillary gels were assembled vertically in a BioRad Protean II 
xi 2 -D cell. Up to approximately 400 pig of solubilized protein in a 
volume of 50 jil was loaded with a small pipette on top of the gel. 
The lower and upper chambers were filled with the buffer 
solutions. IEF was then carried out at constant voltage of 200V for 
2h, then increased to 500V for another 2h, and finally to 800V for 
16h.
2.8.1.4 Determination of the pH-gradient
A tube gel was run at the same time but without sample. After the 
run, the extruded gel was cut into 1 cm long pieces and each stored 
separately overnight in 1 ml of milliQ-water in an Eppendorf tube 
at room temperature. The pH of the contents each tube was 
measured with a pH-meter after 24h.
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2.8.2 Second dimension SDS-PAGE slab gels
2.8.2.1 Solutions
• Acrylamide/bis - acrylamide (30% total monomer, 2.67% cross­
linking monomer) :
29.2 g acrylamide and 0.8 g Bis - acrylamide were dissolved in 
100 ml milliQ-water overnight in the cold protected from light 
and stored at 4°C.
• 1.5 M Tris-HCL: 18.15 g Tris-HCI was dissolved in 100 ml milliQ 
water and adjusted to pH 8.8 with 1N HCI and stored at 4°C.
• Running buffer: 15 g /l Tris-base
72 g /l glycine 
5 g /l SDS
pH 8.3, stored at 4°C and diluted 1:5 prior to electrophoresis.
• gel composition:
1 0 % 12
acrylamide/ bis-acryl. 33 m I 40 m I
1.5 M Tri HCI pH 8.8 25 m I 25 m I
SDS 10% (w/v) 1 m I 1 m I
mi l l iQ-water 41 m I 34 ml
2.8.2.2 Gel preparation
The components were mixed and degassed. 50 pi TEMED and 500 pi 
10% (w/v) APS were added. The acrylamide solution was pipetted 
between the glass plates to produce a gel of 1.5 mm thickness and 
of 18 cm x 20 cm in size. The acrylamide solution was allowed to 
polymerize for 60 min. The acrylamide was overlayed with 35% 
ethanol to create a smooth horizontal interface.
2.8.2.3 Running the second dimension
The capillary gel was extruded with an attached syringe after the 
run and then transferred onto the dry top of the slab gel. Here the 
tube gel was fixed with warm 4% DNA-grade-agarose and then 
stained by pipetting a small volume of Coomassie Blue solution 
along the gel to mark the running front. The slab gel was then
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attached to a cooling core and assembled in a BioRad Protean II xi- 
2D cell. The diluted running buffer was filled into both chambers 
and a current of 40 mA/ gel was applied for almost 6h until the 
running front reached the bottom of the gel.
2.8.2.4 Staining and scanning of the gels
After the run, the Protean II xi-2D cell was disassembled, the 
glass plates removed and the gels transferred into a silver- 
staining bath (Dunn & Crisp, 1994). A silver-staining kit from 
NOVA was used. The instructions were altered as time periods for 
each step had to be doubled because of the thickness of the gel. The 
silver-stained gels were scanned using a BioRad Model GS670 
scanning-laser-densitometer.
3.RESULTS
3.1 Induction of apoptosis
The addition of the apoptosis inducers hydroxyurea/6-DMAP, 
colchicine, and okadaic acid to cell cultures of HeLa (Meikrantz et 
al., 1994), HL60 (Martin & Cotter, 1990) and MCF-7 (Boe et al., 
1991) cells respectively, resulted in apoptosis and death of the 
whole population within 48-72h. Apoptotic HL60 cells are noticed 
by different and 'blebby' shapes in the first 24h. The adherent HeLa 
and MCF-7 cells first rounded up and then dislodged during the 
first 24h after induction of apoptosis. In the following hours, more 
and more cells shrank and formed apoptotic bodies. Finally, after 
ca. 48-72h only cell debris * remained. For the cell membrane 
preparation, cells that were apoptotic but still intact were 
required in order to minimize any possible proteolytic alterations 
of the proteins. Therefore, apoptotic cells were harvested after 
24h before most of the cells disintegrate.
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Fig. 9a: normal HeLa cells, m agnification 500x.
Fig. 9b: apoptotic HeLa cells 24h after the induction of apoptosis,
m a g n ific a tio n  400x.
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Fig. 10b: apoptotic HL60 cells 24h after the induction of apoptosis,
m ag n ifica tio n  500x.
4 7
Fig. 11a: norm al MCF-7 cells, m agnification 400x.
Fig. 11b: apoptotic MCF-7 cells 24h after the induction of apoptosis,
m a g n ific a tio n  500x.
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3.2 Cell membrane preparation
A p p ro x im a te ly  2 x  10 8 ce lls , n o rm a l and  a p o p to tic  from  all th re e  
ce ll lin e s , w ere  used  fo r  each  p re p a ra tio n . M ito ch o n d ria  and o th e r 
ce ll o rg a n e lle s  w e re  p e lle te d  by c e n tr ifu g a tio n  a t low  sp e e d  (2000  
rpm ). T h e  s u p e rn a ta n t then  w as c e n tr ifu g e d  at high sp eed  (2 00 0 0  
rp m ), so  th a t th e  c e ll m e m b ra n e  fra c t io n s  fo rm e d  a p e lle t. 
C y to p la s m ic  p ro te in s  in th e  s u p e rn a ta n t w e re  d is c a rd e d  a t th is  
s ta g e . The  ce ll m e m b ra ne  p e lle t w as w ashed  tw ice  to  rem ove  any 
re s id u a l c y to p la s m ic  p ro te in s . T h is  m ethod  is a s ta n d a rd  p ro c e d u re ' 
fo r  is o la t in g  a to ta l m e m b ra n e  fra c tio n  (G ra h a m , 1 9 9 3 ). T h e  
p ro te in  c o n c e n tra tio n  o f the  m e m b ra n e  fra c tio n  w ere  d e te rm in e d  
w ith  th e  B C A  m ic ro  a ssa y. A b s o rb a n ce s  of d ilu te d  sa m p le s  w ere  
co m p a re d  to BS A s ta n d a rd s . Q u a n tita tive  ana lys is  of the m e m brane  
fra c tio n  in d ica ted  ca. 1m g of m em brane  pro te in  per p rep a ra tio n .
T he  p ro te in s  w e re  s to re d  in P B S / E D TA  fo r the  im m u n iza tio n  of 
m ice , b u t w e re  s o lu b iliz e d  to  g e t a g re a te r c o n c e n tra tio n  in a 








0 25 50 75 1 00 125 [BSA] ug/ml
Fig. 12: BCA micro assay; absorbances at 595nm vs BSA concentration.
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3.3 The generation of antibodies specific for 'apoptotic 
proteins'
Bloodsamples were taken from the immunized mice and tested by 
ELISA for antibodies reactive with apoptotic antigens (2.7.2). Very 
few, if any were detected in the bloodserum of the mice inoculated 
with MCF-7 membrane proteins (data not shown).
The MCF-7 serum further tested for the existence of antibodies 
specific for 'apoptotic proteins'. The anti-serum was repeatedly 
incubated with normal cells in order to deplete the serum of 
antibodies reactive with 'normal proteins'. (Fig. 13a) shows a 
decrease in staining of fluorescence after three incubations, 
suggesting that less antibodies reactive with 'normal proteins' are 
present in the remaining supernatant. The supernatant was then 
incubated with apoptotic cells. (Fig. 13b) shows that the apoptotic 
cells have an almost not measurable higher staining of 
fluorescence than the normal cells. This indicates only a few 
antibodies directed against 'apoptotic proteins' and confirms the 
data from the ELISA tests.
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Fig. 13: a) p o lyc lo n a l a n tib o d y  d e p le tio n  w ith  norm al M C F -7  ce lls; 
1st. (red), 2nd. (g reen), and 3rd. (blue), 




S e v e ra l d iffe re n t pH g ra d ie n ts  w ere  te s te d  by va ry in g  the ra tio  o f 
th e  c o n c e n tra tio n s  o f the  a m p h o ly te s  3 /10 , 5 /7 , and 5/8. F ina lly , a 
ra tio  o f 1 :4  fo r  th e  a m p h o ly te s  3 /1 0  and  5 /8  w as ch o se n . T h is  
e s ta b lis h e d  a pH g ra d ie n t w h ich  co ve rs  the  pH range of 4 .7  to  7 .6  
(F ig . 14). T h is  re su lte d  in a sm a ll n u m b e r o f u n fo cu se d  p ro te in s  
fro m  the  ve ry  ac id ic  and basic pH a rea  in the  second  d im ension.
p H -g ra d ie n t
Fig. 14: pH gradient fo r the firs t dimension.
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3.4.2 SDS-PAGE
G els  w ith  7 .5% , 10% , and 12%  acry la m id e  co n te n t w ere  tes ted . 12% 
g e ls  p roved  to  be the  best cho ice  as m ost of the  p ro te ins  a p p e a r to 
be of low  m o le c u la r w e ig h t w ith  an is o e le c tr ic  p o in t (p i) o f 5 .6  to 
7 .2 . Up to  th re e  ge ls  fo r norm al and a p o p to tic  ce lls  and per ce ll line 
w e re  a n a ly z e d . T h e  g e ls  w e re  lo a d e d  w ith  the  sam e a m o u n t of 
p ro te in  and run u n d e r the  sam e co n d itio n s . C o rre sp o n d in g  se c tio n s  
fro m  g e ls  s h o w in g  the  p ro te in  p ro file  from  n o rm a l and  a p o p to tic  
g e ls  d e m o n s tra te  th a t som e sp o ts  a p p e a r o n ly  on the  ge ls  from  
a p o p to tic  p ro te in  p ro file s . The  w ho le  p ro te in  p ro file  can be seen in 
the  a p p e n d ix .
Fig. 15: Sections from  MCF-7 2-D electrophoretogram s.
normal apoptotic
n — t— n
6.2 5.9 5.8 5.6 pH
6.2 5.9 5.8 5.6 pH
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Fig. 16: Sections from HeLa 2-D electrophoretograms.
normal apoptotic
6.3 6.2 5.9 5.8 5.6
I I I I I
6.3 6.2 5.9 5.8 5.6 pH
Fig. 17: Sections from HL60 2-D electrophoretograms.
normal apoptotic
5.6 5.8 5.9 6.2 6.3 6.5
---1----1--- 1----1 I I




It was the purpose of this thesis to show that changes in protein 
expression occur in cell membranes of cells undergoing apoptosis. 
This was attempted by
(i) the generation of antibodies reactive with apoptotic antigen;
(i i ) the analysis of the whole protein profile by 2D-PAGE.
As a result, at least two proteins per cell line were found to 
appear only on the apoptotic electrophoretograms, suggesting that 
a change in protein distribution in the cell membranes of 
mammalian cells during apoptosis occurs.
Apoptosis is an active cell process which requires energy and gene 
expression. Several so called death genes have been identified in 
the nematode C. elegans whose protein products are implicated in 
apoptosis. These proteins are only expressed in the event of 
apoptosis. They function as blockers or enhancers in signal 
transduction, in the formation of apoptotic bodies, and regulate 
phagocytic uptake. In mammalian cells, similar genes and proteins 
have been identified to a lesser extent and much is still unknown 
about changes in protein expression during apoptosis. ‘Apoptotic 
proteins' can originate from de novo or upregulated gene expression 
during apoptosis or may be post-transcriptionally altered during 
apoptosis.
Owing to the likelihood that ‘apoptotic’ proteins may be involved in 
signal transduction pathways and as mediators of phagocytotic 
uptake, it was reasoned that at least some would be membrane- 
associated proteins.
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The 2D-electrophoretograms showed a number of proteins that are 
expressed only during apoptosis in the membranes of the cells 
studied. At least two proteins of MCF-7 cells, two of HL60 cells 
and two of HeLa cells were found on the apoptotic electrophoreto- 
grams but not on the normal corresponding ones. The two proteins 
found on the apoptotic MCF-7 electrophoretograms (Fig. 15), as 
well as one of the proteins from the HL60 and HeLa apoptotic 
electrophoretograms each had the same pi of 5.9 (Fig. 16, 17). The 
other two proteins from the HL60 and HeLa cells had a pi of 6.2. 
The MCF-7 proteins had a higher molecular weight, according to 
their position on the gels, than those from the other cell lines. The 
HeLa and HL60 proteins with the pi of 5.9 and the proteins with the 
pi of 6.2 had quite similar molecular weights. But, because 
molecular weight standards were not used and the apoptotic gels 
were not run at the same time, it is not clear whether these 
proteins are identical. It could not be determined whether these 
proteins were newly expressed during apoptosis or had been 
altered for the purpose of apoptosis or resulted from proteolysis 
of pre-existing proteins by proteases activated during apoptosis. 
Further identification and characterization of the ‘apoptotic 
proteins' was hampered by a low amount of ‘apoptotic proteins' and 
a lack of apoptotic antibodies. The subtractive immunization of 
mice with cell membrane proteins from apoptotic cells produced 
only a very small number of antibodies.
4.2 Cell lines and membrane preparation
The HeLa, HL60, and MCF-7 cell lines used in this study provided a 
number of features which made them suitable for studies on 
protein expression in cell membranes during apoptosis. These cells
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can be easily grown in large numbers in a short period of time 
without special requirements for growth medium or other 
conditions. Another important fact is that conditions are known 
which induce apoptosis in these cells within 48-72h (Boe et al., 
1991; Meikrantz et al., 1994; Martin & Cotter, 1990).
Apoptosis is an individual cell process which does not affect all 
cells at the same time. In the early stages of apoptosis, in a cell 
culture normal cells and cells in all morphological stages of 
apoptosis can be observed. Because protein expression has to occur 
in the early stages of apoptosis before the degradation of DNA 
takes place, apoptotic cells were harvested after 24h when 
approximately 50% of the cell population was apoptotic but before 
the break up into apoptotic bodies.
Much is not known about changes in protein expression during 
apoptosis. Therefore, the whole protein profile of the cell 
membranes was targeted in this investigation. Cytoplasmic 
proteins were not examined because of the already complex 2D- 
electrophoretograms and limiting time. The technique used for the 
preparation of the membrane proteins provided a simple and fast 
method and yielded large amounts of proteins.
4.3 2D-PAGE
The 2D-PAGE method proved to be a powerful technique for the 
separation of hundreds of proteins. Sophisticated equipment for the 
comparison of gels with hundreds of protein spots was not 
available locally, so that different spots had to be detected 
visually. This action detected major spot differences but probably
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did not detect any minor changes in spot distribution. A loss of 
information cannot be excluded. The limiting step in this technique 
is the first dimension. Only a small sample volume can be loaded 
onto the tube gels. Although the solubilization of the proteins 
provided an improvement in the total protein that could be loaded, 
400pg of total protein was the maximum load. Due to the small 
amount of total protein analyzed, but the large number of different 
proteins, the spots had to be visualized by silver-stain.
4.4 Generation of antibodies reactive with ‘apoptotic’ 
antigen
The raising of antibodies against apoptotic proteins was an effort 
to produce probes that could be used in western blotting and for 
the detection of apoptotic markers on cells by flow cytometry. The 
subtractive immunization method is designed to produce a greater 
response to rare antigens by the suppressed response to more 
common antigens (Matthew/Sandrock, 1987). This is achieved by 
the administration of cyclophosphamide. The ELISA tests and the 
more sensitive analysis by flow cytometry showed that only a very 
small number of antibodies had been raised against apoptotic 
antigens (Fig. 13b).
5. CONCLUSIONS
Despite growing interest and research into the regulation of 
apoptosis in recent years, the whole process is still poorly 
understood.
This study attempted to investigate changes of protein expression 
in the cell membranes of cells undergoing apoptosis. The results 
suggest that a change in protein expression in the cell membranes
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of cells undergoing apoptosis occurs as several proteins were 
found only on the apoptotic electrophoretograms. However, it could 
not be determined whether these proteins were newly expressed or 
originated from proteolytic reactions between normal proteins and 
proteases activated during apoptosis. The methods and techniques 
used in this study were not able to produce these results. Further 
studies investigating especially 'apoptotic proteins' have to make 
major improvements and modifications of these techniques.
A major problem was the limited amount of total membrane 
protein which could be loaded onto the tube gels if precipitation 
was to be avoided. By using longer tube gels with a greater 
diameter, a larger amount of protein could be loaded onto the gels. 
The increased diameter would provide an easier access for the 
proteins to migrate into the gel and reduce the risk of 
precipitation. Different pH-gradients, for example those covering 
the extreme acidic and basic pH range, could focuse proteins which 
appear as blurry spots with the current pH-gradient. Gradient gels 
could also contribute to a better resolution of a protein profile, i.e. 
better separated and more focused protein spots.
The interpretation of the 2D-electrophoretograms would be easier 
by a reduced number of protein spots. In order to reduce the total 
number of proteins and increase the amount of a single protein in a 
sample, different membrane fractions could be selected. This could 
be achieved by using differential centrifugation and density- 
gradient centrifugation techniques. By using molecular weight 
standards, it should then by possible to produce electrophoreto­
grams with a reduced number of protein spots with known pi and
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molecular weight. Proteins with identical pi's and masses 
appearing in all three cell lines, would further identify possible 
'apoptotic proteins'.
By metabolic labelling with 35S-methionine/14C-leucine for a 1-4h 
pulse during apoptosis, newly expressed proteins could be tagged 
and distinguished by autoradiography or phosphorimaging on the 
2D-gels from those proteins which resulted from proteolysis of 
normal proteins during apoptosis. Indication of a unique protein 
generated during apoptosis could be obtained by N-terminal 
sequence analysis.
With the increased capacity of the first dimension and repeated 
runs it should be possible to obtain enough protein (100 pmol) for 
N-terminal sequence analysis. Otherwise, mAbs could be used in 
affinity chromatography columns to further specifically con­
centrate the proteins. When a sequence can be obtained, the 
comparison to data of a gene bank would identify a new 
gene/protein when no match can be found.
A different approach to identify ‘apoptotic proteins’ would be not 
to target the protein but its mRNA. A technique recently intro­
duced by CLONTECH produces cDNAs from rare mRNAs by 
subtractive PCR (polymerase chain reaction). The produced cDNAs 
then can be used for cloning as well as sequence analysis. The 
proteins can be cloned and overexpressed and then compared to 
those obtained from 2D-PAGE. At this stage, cytoplasmic proteins 
should also be included into the investigation as certainly their 
mRNAs are also found.
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